287 related articles for article (PubMed ID: 8344409)
1. Plasmodium falciparum: analysis of the cytoadherence inhibition of the human monoclonal antibody 33G2 and of antibodies reactive with antigen Pf332.
Iqbal J; Perlmann P; Berzins K
Exp Parasitol; 1993 Aug; 77(1):79-87. PubMed ID: 8344409
[TBL] [Abstract][Full Text] [Related]
2. Immunogens containing sequences from antigen Pf332 induce Plasmodium falciparum-reactive antibodies which inhibit parasite growth but not cytoadherence.
Ahlborg N; Iqbal J; Hansson M; Uhlén M; Mattei D; Perlmann P; Stahl S; Berzins K
Parasite Immunol; 1995 Jul; 17(7):341-52. PubMed ID: 8552406
[TBL] [Abstract][Full Text] [Related]
3. Reactivity of the human monoclonal antibody 33G2 with repeated sequences of three distinct Plasmodium falciparum antigens.
Udomsangpetch R; Carlsson J; Wåhlin B; Holmquist G; Ozaki LS; Scherf A; Mattei D; Mercereau-Puijalon O; Uni S; Aikawa M
J Immunol; 1989 May; 142(10):3620-6. PubMed ID: 2654292
[TBL] [Abstract][Full Text] [Related]
4. Cytoadherence of knobless Plasmodium falciparum-infected erythrocytes and its inhibition by a human monoclonal antibody.
Udomsangpetch R; Aikawa M; Berzins K; Wahlgren M; Perlmann P
Nature; 1989 Apr; 338(6218):763-5. PubMed ID: 2566118
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium falciparum: differential parasite growth inhibition mediated by antibodies to the antigens Pf332 and Pf155/RESA.
Ahlborg N; Iqbal J; Björk L; Ståhl S; Perlmann P; Berzins K
Exp Parasitol; 1996 Mar; 82(2):155-63. PubMed ID: 8617342
[TBL] [Abstract][Full Text] [Related]
6. Epitope specificity and capacity to inhibit parasite growth in vitro of human antibodies to repeat sequences of the Plasmodium falciparum antigen Ag332.
Ahlborg N; Flyg BW; Iqbal J; Perlmann P; Berzins K
Parasite Immunol; 1993 Jul; 15(7):391-400. PubMed ID: 7692377
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and antigenic properties of Pf332-C231, a fragment of a non-repeat region of the Plasmodium falciparum antigen Pf332.
Balogun HA; Vasconcelos NM; Lindberg R; Haeggström M; Moll K; Chen Q; Wahlgren M; Berzins K
Vaccine; 2009 Dec; 28(1):90-7. PubMed ID: 19822232
[TBL] [Abstract][Full Text] [Related]
8. Pf332-C231-reactive antibodies affect growth and development of intra-erythrocytic Plasmodium falciparum parasites.
Balogun HA; Awah NW; Farouk SE; Berzins K
Vaccine; 2011 Dec; 30(1):21-8. PubMed ID: 22064263
[TBL] [Abstract][Full Text] [Related]
9. Plasmodium falciparum: an epitope within a highly conserved region of the 47-kDa amino-terminal domain of the serine repeat antigen is a target of parasite-inhibitory antibodies.
Fox BA; Xing-Li P; Suzue K; Horii T; Bzik DJ
Exp Parasitol; 1997 Feb; 85(2):121-34. PubMed ID: 9030663
[TBL] [Abstract][Full Text] [Related]
10. Seroreactivity with the Plasmodium falciparum blood stage antigen Pf332 in adults and children from malaria-endemic regions.
Iqbal J; Perlmann P; Greenwood BM; Berzins K
Clin Exp Immunol; 1993 Oct; 94(1):68-74. PubMed ID: 8403520
[TBL] [Abstract][Full Text] [Related]
11. Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum.
Dutta S; Haynes JD; Barbosa A; Ware LA; Snavely JD; Moch JK; Thomas AW; Lanar DE
Infect Immun; 2005 Apr; 73(4):2116-22. PubMed ID: 15784553
[TBL] [Abstract][Full Text] [Related]
12. Humoral immune responses to Plasmodium falciparum antigens in children and adults living in a hypoendemic area of Punjab (Pakistan).
Iqbal J; Rab A; Perlmann P; Berzins K
Am J Trop Med Hyg; 1994 Oct; 51(4):444-53. PubMed ID: 7943571
[TBL] [Abstract][Full Text] [Related]
13. Definition of the epitope recognized by the Plasmodium falciparum-reactive human monoclonal antibody 33G2.
Ahlborg N; Berzins K; Perlmann P
Mol Biochem Parasitol; 1991 May; 46(1):89-95. PubMed ID: 1712912
[TBL] [Abstract][Full Text] [Related]
14. Analysis of a human monoclonal antibody reactive with multiple Plasmodium falciparum antigen repeat sequences using a solid phase affinity assay.
Ahlborg N; Larsson A; Perlmann P; Berzins K
Immunol Lett; 1993 Aug; 37(2-3):111-8. PubMed ID: 7504999
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
16. Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites.
Costa FT; Fusaï T; Parzy D; Sterkers Y; Torrentino M; Douki JB; Traoré B; Petres S; Scherf A; Gysin J
J Infect Dis; 2003 Jul; 188(1):153-64. PubMed ID: 12825185
[TBL] [Abstract][Full Text] [Related]
17. Antibodies from malaria-exposed pregnant women recognize trypsin resistant epitopes on the surface of Plasmodium falciparum-infected erythrocytes selected for adhesion to chondroitin sulphate A.
Sharling L; Enevold A; Sowa KM; Staalsoe T; Arnot DE
Malar J; 2004 Sep; 3():31. PubMed ID: 15350207
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium falciparum: a comparison of the activity of Pfs230-specific antibodies in an assay of transmission-blocking immunity and specific competition ELISAs.
Roeffen W; Beckers PJ; Teelen K; Lensen T; Sauerwein RW; Meuwissen JH; Eling W
Exp Parasitol; 1995 Feb; 80(1):15-26. PubMed ID: 7529717
[TBL] [Abstract][Full Text] [Related]
19. Pf 155, a candidate for a blood stage vaccine in Plasmodium falciparum malaria.
Berzins K; Perlmann H; Udomsangpetch R; Wåhlin B; Wahlgren M; Troye-Blomberg M; Carlsson J; Björkman A; Perlmann P
Dev Biol Stand; 1985; 62():99-106. PubMed ID: 3914427
[TBL] [Abstract][Full Text] [Related]
20. Band 3 clustering promotes the exposure of neoantigens in Plasmodium falciparum-infected erythrocytes.
Winograd E; Prudhomme JG; Sherman IW
Mol Biochem Parasitol; 2005 Jul; 142(1):98-105. PubMed ID: 15907563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
